Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL2020 in ST-elevation myocardial infarction (confirmatory study)
jRCT1080224979Phase 3Completed
- Sponsor
- Life Science Institute
- Start
- Dec 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing CL2020 with Placebo (2 arms). Primary endpoint: Change from baseline in LVEF at Week 24 (echocardiography). Started Dec 2019; status: completed.
02
Drugs
CL2020
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on jRCT1080224979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224979.